Reliability of the In Silico Prediction Approach to In Vitro Evaluation of Bacterial Toxicity

Related Experiment Video

Updated: Jun 21, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.0K

Sung-Yoon Ahn1, Mira Kim2, Ji-Eun Bae2

  • 1Pattern Recognition and Machine Learning Lab, Department of AI Software, Gachon University, Seongnam 13557, Korea.

Sensors (Basel, Switzerland)
|September 9, 2022
PubMed

Insights

This study uses deep learning to predict airborne bacterial toxicity in indoor air, aiding disease prevention and improving air quality. The AI model accurately identifies potentially harmful bacteria from protein sequences, enhancing public health strategies.

Area of Science:

  • Environmental microbiology
  • Computational biology
  • Infectious disease epidemiology

Background:

  • Airborne pathogens pose significant risks to human health, particularly in indoor environments, as highlighted by the COVID-19 pandemic.
  • Contaminated indoor air with viruses, bacteria, and fungi can lead to various health issues.
  • Effective identification of airborne pathogens is essential for disease prevention and maintaining healthy indoor air quality.

Purpose of the Study:

  • To develop and apply deep learning technology for analyzing and predicting the toxicity of bacteria present in indoor air.
  • To assess the potential of computational methods in identifying pathogenic bacteria based on their protein sequences.
  • To enhance strategies for preventing infectious diseases transmitted through indoor air.

Main Methods:

  • Utilized deep learning, specifically the ProtBert model, trained on toxic bacterial and virulence factor proteins.
  • Applied the trained model to predict the toxicity of bacterial species by analyzing their protein sequences.
  • Validated the in silico predictions against in vitro analyses of bacterial toxicity in human cells.

Main Results:

  • The deep learning model successfully predicted bacterial toxicity, with results aligning with in vitro experimental findings.
  • The study demonstrated the plausibility of identifying potential toxic protein sequences within unknown bacterial samples.
  • The computational approach proved effective in assessing the pathogenic potential of airborne bacteria.

Conclusions:

  • Deep learning offers a powerful tool for predicting airborne bacterial toxicity and identifying potential health threats in indoor environments.
  • In silico analysis of protein sequences can reliably predict bacterial pathogenicity, complementing traditional laboratory methods.
  • This research contributes to improved methods for monitoring indoor air quality and preventing the spread of airborne infectious diseases.
Keywords:
BERTproteintoxinvirulence factors

More Related Videos

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

11.8K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K

Related Concept Videos

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...